203 related articles for article (PubMed ID: 17449347)
1. Molecular mechanisms in Barrett's metaplasia and its progression.
Izzo JG; Luthra R; Wu TT; Correa AM; Luthra M; Anandasabapathy S; Chao KS; Hung MC; Aggarwal B; Hittelman WN; Ajani JA
Semin Oncol; 2007 Apr; 34(2 Suppl 1):S2-6. PubMed ID: 17449347
[TBL] [Abstract][Full Text] [Related]
2. The molecular biology of esophageal adenocarcinoma.
Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
4. [Risk estimation in Barrett's esophagus: biomolecular marker and histopathologic classification].
Walch A; Schmitt-Gräff A; Stein H; Werner M
Zentralbl Chir; 2002 Dec; 127(12):1073-7. PubMed ID: 12529823
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in Barrett's oesophagus.
Dias Pereira A; Suspiro A; Chaves P
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
[TBL] [Abstract][Full Text] [Related]
7. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in Barrett's esophagus and esophageal adenocarcinoma.
Dinjens WN
Minerva Chir; 2002 Dec; 57(6):733-52. PubMed ID: 12592217
[TBL] [Abstract][Full Text] [Related]
9. Editorial: One small step for metaplasia, but one giant leap for biomarkers is needed.
Nicholson A; Jankowski J
Am J Gastroenterol; 2009 Nov; 104(11):2681-3. PubMed ID: 19888234
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
[TBL] [Abstract][Full Text] [Related]
11. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
Fléjou JF
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of Barrett's cancer.
Atherfold PA; Jankowski JA
Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
[TBL] [Abstract][Full Text] [Related]
13. Secretory phospholipase A2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model.
Babu A; Meng X; Banerjee AM; Gamboni-Robertson F; Cleveland JC; Damle S; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1220-7. PubMed ID: 18544357
[TBL] [Abstract][Full Text] [Related]
14. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
15. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
16. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997.
Morgan G
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):265. PubMed ID: 9521445
[No Abstract] [Full Text] [Related]
17. [Oesophageal and gastric pathology: early neoplastic lesions. case 2 and case 3. Dysplasia and superficial cancer on Barrett's oesophagus].
Fléjou JF
Ann Pathol; 2011 Oct; 31(5):363-8. PubMed ID: 21982243
[No Abstract] [Full Text] [Related]
18. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic precursor lesions in Barrett's esophagus.
Hornick JL; Odze RD
Gastroenterol Clin North Am; 2007 Dec; 36(4):775-96, v. PubMed ID: 17996790
[TBL] [Abstract][Full Text] [Related]
20. [Barrett's esophagus. Metaplasia-dysplasia-cancer: inexorable change?].
Tamayo de la Cuesta JL
Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():40-4. PubMed ID: 15146792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
